M.A. van Osch and G.J. Mulder
Fcpm Iii Services B.v.
Assets Managed
$722.207M
Holdings
10
Last Quarter
2026 - Q1
Filed Date
11d ago
Growth Rate
-5.33%(2Q avg: 23.57%)
Sustained Growth
0 quarters
Portfolio positions
This chart displays the top 10 holdings in Fcpm Iii Services B.v.'s 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 10 positions.
Assets under management
The assets under management (AUM) of Fcpm Iii Services B.v. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 722.207M in assets, with a quarterly growth rate of -5.33% and a 2-quarter average growth rate of 23.57%. The portfolio is managed by M.A. van Osch and G.J. Mulder, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
NAMS Newamsterdam Pharma Co Nv
| 40.78% | $294.457M 9.199M shares@ $32.01 avg price | |
DYN Dyne Therapeutics Inc
| 11.66% | $84.203M 4.644M shares@ $18.13 avg price | Decreased -14.98% |
VOR Vor Biopharma Inc
| 10.18% | $73.454M 4.117M shares@ $17.84 avg price | Increased 13.83% |
ENGN Engene Holdings Inc
| 9.09% | $65.598M 9.633M shares@ $6.81 avg price | |
MPLT Maplight Therapeutics Inc
| 9.09% | $65.593M 3.226M shares@ $20.33 avg price | |
GLTO Galecto Inc
| 8.76% | $63.222M 2.441M shares@ $25.9 avg price | New Position |
CBIO Crescent Biopharma Inc
| 4.27% | $30.822M 1.678M shares@ $18.37 avg price | |
REPL Replimune Group Inc
| 2.98% | $21.484M 2.808M shares@ $7.65 avg price | |
BCYC Bicycle Therapeutics Plc-adr
| 2.23% | $16.094M 3.468M shares@ $4.64 avg price | |
ENGNW Engene Holdings Inc-28
| 1.01% | $7.282M 2.878M shares@ $2.53 avg price |
1-10 of 10